
    
      The purpose of this study is to evaluate the safety of Minocin IV and measure plasma,
      epithelial lining fluid, and alveolar macrophage drug levels after six doses of Minocin IV
      given 12 hours apart, administered as 1-hour infusions in healthy adult subjects.
    
  